인쇄하기
취소
|
The Ministry of Health and Welfare(MOHW) will tighten social responsibilities and ethical standards on innovative pharmaceutical companies.
In response to a recent criticism “It is irrational to provide preferential treatments, such as drug prices, preferred support for R&D and tax benefits, to companies having a low sense of social ethics by certifying them as ‘innovative pharmaceutical compa...